Clinical Trial Update: A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial evaluating PDC-1421 for major depressive disorder in cancer patients; recruitment status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• PDC-1421

Snippet

Sponsor: BioLite, Inc. | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING